Parkside Investments’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-75,925
Closed -$634K 85
2022
Q2
$634K Sell
75,925
-172,500
-69% -$2.41M 0.13% 71
2022
Q1
$5.68M Buy
248,425
+21,850
+10% +$534K 1.11% 34
2021
Q4
$6.25M Buy
226,575
+1,275
+0.6% +$34.1K 1.2% 31
2021
Q3
$6.27M Buy
225,300
+42,150
+23% +$1.2M 1.31% 27
2021
Q2
$6.25M Sell
183,150
-44,775
-20% -$1.36M 1.2% 29
2021
Q1
$7.23M Sell
227,925
-275
-0.1% -$8.07K 1.51% 20
2020
Q4
$4.75M Buy
228,200
+193,200
+552% +$3.6M 1.05% 36
2020
Q3
$543K Hold
35,000
0.14% 81
2020
Q2
$640K Buy
35,000
+10,000
+40% +$176K 0.17% 83
2020
Q1
$387K Hold
25,000
0.13% 84
2019
Q4
$748K Buy
25,000
+1,100
+5% +$28.6K 0.18% 82
2019
Q3
$522K Buy
23,900
+1,800
+8% +$41.2K 0.14% 80
2019
Q2
$557K Buy
+22,100
New +$525K 0.14% 88

Other funds holding BHC

Parkside Investments's BHC Position: Q3 2022 in Review

Parkside Investments sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 75,925 shares — an estimated $634K sold.

Parkside Investments first reported a position in BHC in Q2 2019 and held it in 13 quarters. The position peaked at $7.23M in Q1 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Parkside Investments reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Parkside Investments sold 75,925 Bausch Health shares in Q3 2022, an estimated $634K.
  • Parkside Investments first reported a position in Bausch Health in Q2 2019 and held it in 13 quarters.
  • Parkside Investments's Bausch Health position peaked at $7.23M in Q1 2021.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Parkside Investments's 13F filing for Q3 2022, filed 20 Oct 2022.